Turkey Tail (Trametes versicolot) — What the Research Actually Shows
Last updated: 27/10/2026
Here's every claim about Turkey Tail, graded by how strong the actual evidence is. Links included where I have them.
A note on tradition
Turkey tail has a long history in Asian medicine — called Yun Zhi in China and Kawaratake in Japan — and has traditionally been taken as a tea or decoction of the dried mushroom. A Ming dynasty Chinese materia medica is the usual earliest reference, and it was used as a general tonic and for liver and respiratory complaints. That's not scientific proof of anything. But that much sustained use, in a mild water-based form, with no established pattern of harm, does suggest it's reasonably well tolerated, and a reputation that old may point to effects modern research hasn't measured yet. In Japan, it is used as adjuvant cancer treatment since 1976. Worth noting: the modern trials tested concentrated extracts (PSK, PSP), not the traditional tea.
Cancer survival (gastric, colorectal, breast) — alongside chemo
Type: Human trials — Evidence: Medium Several randomized trials, mostly in Japan, found patients on PSK plus chemo lived longer on average than those on chemo alone. A 2012 pooled analysis of 13 trials (about 2,600 patients) found a 9% drop in 5-year mortality, seen in breast, stomach, and colon cancer — but not in esophageal or nasopharyngeal cancer. A 2019 analysis of 23 trials pointed the same way on survival but found no significant difference in how long patients stayed cancer-free. The benefit also depends on stage: in one 918-patient gastric trial it helped mid-stage patients but not early or late-stage ones. Some trials found no difference at all — two newer Japanese phase 3 colon and rectal trials found no benefit from adding PSK — and Cochrane rates the colon cancer evidence as low certainty.
https://www.researchgate.net/publication/51903555_Efficacy_of_Yun_Zhi_Coriolus_versicolor_on_Survival_in_Cancer_Patients_Systematic_Review_and_Meta-Analysis
https://www.cochrane.org/evidence/CD012053_coriolus-versicolor-mushroom-colorectal-cancer
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687673/
https://www.cancer.gov/about-cancer/treatment/cam/hp/mushrooms-pdq
Lung cancer — alongside chemo
Type: Human trials — Evidence: Weak A review of 28 studies found mostly positive signals (survival, symptoms, immune markers), but they leaned on small and non-randomized trials. One small double-blind trial (34 patients) gave PSP for 28 days after treatment for advanced lung cancer and found some slowing of decline, but no improvement in lung cancer symptoms. The authors themselves call for larger trials.
https://journals.sagepub.com/doi/10.1177/1534735415572883
Breast cancer (after chemo and radiation)
Type: Human trial — Evidence: Weak A phase 1 trial enrolled 11 women with early breast cancer, giving mushroom powder after radiation at escalating doses. Its goal was safety and tolerability, not showing it works, and it's far too small.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369477/
Immune markers in cancer patients
Type: Lab/animal studies — Evidence: Medium This is the most consistent thing turkey tail does in people. In lung cancer trials, PSK was linked to higher white blood cell counts, antibody levels, NK cell activity, and CD4 T cells, and to shorter chemo-related drops in blood counts. The 2019 pooled analysis also found CD3 and CD4 counts up. But a small breast cancer phase 1 trial saw only non-significant trends, with CD8 and B cells up and CD4 not. All of this is in cancer patients on treatment, and none of it shows fewer infections.
https://journals.sagepub.com/doi/10.1177/1534735415572883
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2019.00703/xml
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369477/
Immune support in healthy people
Type: No human Trials — Evidence: None I found no trial testing turkey tail on immune markers or infection rates in healthy people. The only healthy-volunteer trial I found was about gut bacteria. Anyone telling you it boosts the immune system in general is extrapolating from cancer patients and lab work.
HPV (oral)
Type: Human trial — Evidence: Weak A small preliminary randomized trial gave turkey tail plus reishi (200 mg/day, 2 months) to 41 people with oral HPV16/18, and about 88% cleared the virus versus 5% in a comparison group of 20. Striking, but it's a short report, the comparison group took a different mushroom rather than a placebo, and it tested a turkey tail and reishi combination, so I can't credit turkey tail alone. The author himself says it only deserves further investigation.
Antimicrobial activity
Type: Lab studies — Evidence: Weak Extracts have shown activity against some microbes, including a parasite (Toxoplasma), in cells. Not tested in people.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225767/
Gut microbiome (prebiotic effect)
Type: Human trial — Evidence: Medium This is turkey tail's best-supported non-cancer claim, and still just one trial. 24 healthy volunteers were randomized to PSP, the antibiotic amoxicillin, or nothing. PSP produced clear, consistent shifts in gut bacteria, in line with a prebiotic, and no serious side effects. But each person's baseline microbiome was stable and tended to overshadow the effect, and the trial didn't test whether the changes do anything for your health, or whether PSP helps you recover after antibiotics. Earlier lab work found it boosted Bifidobacterium and Lactobacillus and reduced Clostridium, and a mouse study found similar benefits on gut bacteria and fat build-up in the liver on a high-fat diet.
https://pubmed.ncbi.nlm.nih.gov/25006989/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11356736/
Antioxidant effects
Type: Human trial — Evidence: Weak A small trial of 40 people with Meniere's disease (a vertigo and hearing disorder) gave turkey tail biomass tablets and found lower oxidative stress markers in blood cells, better glutathione balance, and less tinnitus. Real human data, but small, in one specific condition.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981469/
Anti-inflammatory effects
Type: Lab/animal studies — Evidence: Weak Reduced inflammatory markers in mice with colitis and in rat models of pain and diabetic heart damage. I found no human trial testing this directly. One older mouse study even found no immune benefit from a related extract, so the effects aren't clear-cut.
https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Turkey_Tail_Mushrooms.pdf
Blood sugar, cholesterol, bone health
Type: Lab/animal studies — Evidence: Weak Better glucose tolerance, lower blood fats, and thicker bones in diabetic or high-fat-diet rodents. Not tested in people.
https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Turkey_Tail_Mushrooms.pdf
Safety
Type: Clinical trial — Evidence: Strong Well tolerated in the trials, with mild digestive upset the most common issue, and no serious adverse events in the gut trial. PSK has been used as an approved drug in Japan for 40 years. Most of that data is from standardized extracts at 3 g/day, and I don't have long-term data on casual supplement use. No drug interactions have been reported, but since it stimulates the immune system, it could in theory clash with immunosuppressant medication. If you're in cancer treatment or on immune-suppressing drugs, talk to your doctor before taking it.
https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Turkey_Tail_Mushrooms.pdf
Evidence changes — I'll update this as new research comes out.
Contact
Join our WhatsApp group for weekly mushroom updates
Phone
+351 910715365
© 2025. All rights reserved.
+351 910715365
